Zeglis research group at Hunter College presents novel thiol-reactive bifunctional chelators that allow for site-selective labeled conjugated with improved stability and lower uptake in nontarget tissues – makes fighting cancer easier!
Read more: http://bit.ly/2qPVwiP
